Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1066 | 1035 | 1253 | 785 | 1565 | 2442 |
Fund Return | 6.64% | 3.52% | 25.28% | -7.77% | 9.37% | 9.34% |
Place in category | 420 | 273 | 458 | 444 | 274 | 251 |
% in Category | 79 | 47 | 87 | 88 | 60 | 66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artisan International Value Instl | 21.58B | 9.64 | 8.41 | 8.07 | ||
Artisan International Value Advisor | 10.45B | 9.56 | 8.30 | - | ||
Artisan Mid Cap Advisor | 4.2B | 6.54 | -7.86 | - | ||
Artisan Mid Cap Investor | 4.2B | 6.44 | -7.99 | 9.08 | ||
Artisan International Small Cap Ins | 3.14B | 1.87 | -5.37 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.73B | 18.77 | 5.53 | 12.65 | ||
T. Rowe Price Mid-Cap Growth I | 13.6B | 7.79 | 0.27 | - | ||
Vanguard Mid-Cap Growth Index Admir | 12.13B | 11.75 | -0.99 | 10.25 | ||
T. Rowe Price Mid-Cap Growth | 12.75B | 7.68 | 0.14 | 10.48 | ||
T. Rowe Price New Horizons I | 11.06B | 3.91 | -9.99 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 4.64 | 599.35 | +0.91% | |
Tyler Technologies | US9022521051 | 3.76 | 616.87 | -0.36% | |
Ascendis Pharma AS | US04351P1012 | 3.56 | 126.03 | -1.28% | |
Spotify Tech | LU1778762911 | 3.55 | 467.37 | +11.44% | |
West Pharmaceutical Services | US9553061055 | 3.32 | 344.00 | +5.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review